By Notice dated November 21, 2006, and published in the Federal Register on December 1, 2006, (71 FR 69590), Notice of Application, Hospira, Inc., 1776 North Centennial Drive, McPherson, Kansas 67460-1247, paragraph three should be corrected to read as follows: The company plans to import Remifentanil for use in dosage form manufacturing.Start Signature
Dated: January 5, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. E7-309 Filed 1-11-07; 8:45 am]
BILLING CODE 4410-09-P